Literature DB >> 9488106

Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice.

M Wald1, E Závadová, P Poucková, M Zadinová, M Boubelik.   

Abstract

Long-term rectal administration of enzyme mixture containing papain, trypsin and chymotrypsin in the same ratio as the preparation Wobe-Mugos E (Mucos Pharma, Germany) was evaluated for their antitumor effects in C57Bl6 inbred mice inoculated with Bl6 melanoma cells. 30% of animals in the test group (3 pcs) have been cured of cancer. In the rest of animals (70%) the survival time was prolonged by 58.3% compared to the control group (from average survival time of 24 days in control group to 38 days in the test group). Based on histological and immunohistochemical evaluation a faster process of metastasizing was found in control group than in the group treated with the polyenzyme preparation. In the case of melanoma Bl6 an antimetastatic effect of the preparation was thus proved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488106

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.

Authors:  K Poulas; T Tsouloufis; S J Tzartos
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Nutrition and cancer: a review of the evidence for an anti-cancer diet.

Authors:  Michael S Donaldson
Journal:  Nutr J       Date:  2004-10-20       Impact factor: 3.271

3.  Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.

Authors:  Carla A Guimarães-Ferreira; Elaine G Rodrigues; Renato A Mortara; Hamilton Cabral; Fabiana A Serrano; Ricardo Ribeiro-dos-Santos; Luiz R Travassos
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

4.  Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model.

Authors:  Catalina Trejo-Becerril; Enrique Pérez-Cardenas; Blanca Gutiérrez-Díaz; Desiree De La Cruz-Sigüenza; Lucía Taja-Chayeb; Mauricio González-Ballesteros; Patricia García-López; José Chanona; Alfonso Dueñas-González
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.